Knight Therapeutics, Inc. (GUD.TO)
12.06
+0.01
(+0.08%)
CAD |
TSX |
Nov 13, 16:00
Knight Therapeutics Price to Book Value : 1.490 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 1.490 |
| November 12, 2026 | 1.489 |
| November 11, 2026 | 1.487 |
| November 10, 2026 | 1.480 |
| November 09, 2026 | 1.434 |
| November 06, 2026 | 1.411 |
| November 05, 2026 | 1.429 |
| November 04, 2026 | 1.396 |
| November 03, 2026 | 1.392 |
| November 02, 2026 | 1.399 |
| October 30, 2026 | 1.393 |
| October 29, 2026 | 1.409 |
| October 28, 2026 | 1.398 |
| October 27, 2026 | 1.394 |
| October 26, 2026 | 1.437 |
| October 23, 2026 | 1.435 |
| October 22, 2026 | 1.446 |
| October 21, 2026 | 1.446 |
| October 20, 2026 | 1.415 |
| October 19, 2026 | 1.398 |
| October 16, 2026 | 1.364 |
| October 15, 2026 | 1.335 |
| October 14, 2026 | 1.311 |
| October 13, 2026 | 1.320 |
| October 09, 2026 | 1.338 |
| Date | Value |
|---|---|
| October 08, 2026 | 1.326 |
| October 07, 2026 | 1.324 |
| October 06, 2026 | 1.303 |
| October 05, 2026 | 1.280 |
| October 02, 2026 | 1.275 |
| October 01, 2026 | 1.315 |
| September 30, 2026 | 1.309 |
| September 29, 2026 | 1.273 |
| September 28, 2026 | 1.263 |
| September 25, 2026 | 1.266 |
| September 24, 2026 | 1.242 |
| September 23, 2026 | 1.241 |
| September 22, 2026 | 1.266 |
| September 21, 2026 | 1.252 |
| September 18, 2026 | 1.261 |
| September 17, 2026 | 1.258 |
| September 16, 2026 | 1.231 |
| September 15, 2026 | 1.225 |
| September 14, 2026 | 1.232 |
| September 11, 2026 | 1.212 |
| September 10, 2026 | 1.197 |
| September 09, 2026 | 1.218 |
| September 08, 2026 | 1.218 |
| September 04, 2026 | 1.231 |
| September 03, 2026 | 1.235 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| HLS Therapeutics, Inc. | 1.551 |
| Bausch Health Cos., Inc. | -- |
| Cipher Pharmaceuticals, Inc. | 1.721 |
| BioSyent, Inc. | 4.401 |
| Revive Therapeutics Ltd. | -- |
Price to Book Value Related Metrics
| PE Ratio | 74.95 |
| PS Ratio | 2.111 |
| Price to Free Cash Flow | 10.31 |
| Price | 12.06 |
| Earnings Yield | 1.33% |
| Market Cap | 1.185B |
| Operating PE Ratio | 38.02 |
| Normalized PE Ratio | 47.86 |